• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® CARDIOFORM ASD OCCLUDER; TRANSCATHETER, SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® CARDIOFORM ASD OCCLUDER; TRANSCATHETER, SEPTAL OCCLUDER Back to Search Results
Catalog Number ASD32J
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Heart Block (4444)
Event Date 11/01/2023
Event Type  Injury  
Event Description
The following was reported to gore: on november 1, 2023, a patient underwent treatment to close a mal-aligned 15 mm stop-flow balloon sized atrial septal defect without an aortic rim using 32 mm gore® cardioform asd occluder (gca).At the first deployment, the occluder was not gripping rims properly.Only the right atrial disc was re-deployed.The occluder was placed with separation under fluoroscopy, and the occluder was locked.After that, an atrioventricular block was confirmed.It became first-degree, second-degree, and wenckebach's block, therefore atropine sulfate was administered intravenously, but complete atrioventricular block developed.The occluder was removed using the retrieval cord.After the occluder was removed, the patient's electrocardiogram improved after being monitored for a while.A 18 mm figulla flex ii septal occluder (fso) device was successfully implanted.The patient tolerated the procedure.The physician stated that an echo revealed that the occluder did not appear to be interfering with the surrounding tissues.The atrioventricular block may have been caused by a catheter.She thought that 27 mm gca could not be used due to its size, therefore she decided to treat it with fso device.
 
Manufacturer Narrative
The gore® cardioform asd occluder instructions for use states: adverse events associated with the use of the occluder may include but are not limited to: new arrhythmia, such as atrial fibrillation or flutter, requiring treatment.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® CARDIOFORM ASD OCCLUDER
Type of Device
TRANSCATHETER, SEPTAL OCCLUDER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
KENDRICK PEAK MPD B/P
4250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
kathy titus
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key18184070
MDR Text Key328694191
Report Number2017233-2023-04419
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P050006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 11/21/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/21/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberASD32J
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/01/2023
Date Device Manufactured06/27/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age8 YR
Patient SexFemale
Patient Weight26 KG
-
-